Backaches May Be in Your Genes
WebMD News Archive
April 11, 2001 -- "Oh! My aching back!"
It's one complaint that nearly all of humankind has in common. Many people just live with it, putting up with bouts of pain. But for a few select people, back problems are so severe they become chronic and debilitating, often requiring surgery.
Now a group of researchers has identified a genetic abnormality that dramatically increases the risk of one of the most common back disorders -- lumbar disk disease. They hope this genetic defect may eventually be a target for gene therapy.
"This is a breakthrough," study author Leena Ala-Kokko, MD, PhD, associate professor in the Center for Gene Therapy at Tulane University Health Sciences Center in New Orleans, tells WebMD. "It's quite possible that genetic defects may be the major cause of this disease." The research findings appear in the April 11 issue of TheJournal of the American Medical Association.
Lumbar disk disease affects about 5% of the population. It often causes a herniated disk to stick into the spine resulting in sciatica, a severe pain in the lower back radiating down the back of the thigh and knee to the foot. The disease also causes the disks to wear down, or degenerate.
Lumbar disk disease "can be a very nasty disease," Ala-Kokko tells WebMD. Patients "never really recover. [They] go on to have lots of operations, change occupation."
Certain genes regulate the formation of the disks -- the cushions between the bones in your spine -- and the cartilage that surrounds them. Defective genes can interfere with this process.
In analyzing the genes of 171 unrelated Finnish patients with sciatica, researchers found a genetic variation in 12% of patients with lumbar disk disease. Presence of the variation "increases risk of lumbar disk disease about threefold," says Ala-Kokko.
Though the genetic variation does not cause lumbar disk disease, people with this genetic change may be more susceptible to the degenerative forces that lead to the disease.
Although back pain is so common, "we haven't known what causes it," Ala-Kokko says. "This is a breakthrough in understanding the disease, which is very important in diagnosis and treatment. We know you should not operate on some patients because their condition will get worse, but we can't tell those apart from the others. Now we have a tool to start understanding this disease, so one day we can have a targeted treatment."